Preliminary evidence for a matrix metalloproteinase-2 (MMP-2)-dependent shedding of soluble CD40 ligand (sCD40L) from activated platelets

References

• Van Kooten C, Banchereau J. Functional role of CD40 and its ligand. Int Arch Allergy Immunol 1997; 113: 393–399
   PubMed Web of Science ®Google Scholar
• Grewal IS, Flavell RA. CD40 and CD154 in cell-mediated immunity. Annu Rev Immunol 1998; 16: 111–135
   PubMed Web of Science ®Google Scholar
• Lutgens E, Gorelik L, Daemen MJAP, de Muinck ED, Grewal IS, Koteliansky VE, Flavell RA. Requirement for CD154 in the progression of atherosclerosis. Nat Med 1999; 5: 1313–1316
   PubMed Web of Science ®Google Scholar
• Mach F, Schönbeck U, Bourcier T, Bonnefoy JY, Pober JS, Libby P. Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis. Proc Natl Acad Sci USA 1997; 94: 1931–1936
   PubMed Web of Science ®Google Scholar
• Mach F, Schönbeck U, Libby P. CD40 signaling in vascular cells: a key role in atherosclerosis?. Atherosclerosis 1998; 137: S89–S95
   PubMed Web of Science ®Google Scholar
• Pamuk GE, Vural O, Turgut B, Demir M, Pamuk ON, Cakir N. Increased platelet activation markers in rheumatoid arthritis: are they related with subclinical atherosclerosis?. Platelets 2008; 19: 146–154
   PubMed Web of Science ®Google Scholar
• Vaidyula VR, Boden G, Rao AK. Platelet and monocyte activation by hyperglycemia and hyperinsulinemia in healthy subjects. Platelets 2006; 17: 577–585
   PubMed Web of Science ®Google Scholar
• Heeschen C, Dimmeler S, Hamm CW, van den Brand MJ, Boerstma E, Zeiher AM, Simoons ML. Soluble CD40 ligand in acute coronary syndromes. N Engl J Med 2003; 348: 1104–1111
   PubMed Web of Science ®Google Scholar
• Henn V, Slupsky JR, Gräfe M, Anagnostopoulos I, Förster R, Müller-Berghaus G, Kroczek RA. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 1998; 391: 591–594
   PubMed Web of Science ®Google Scholar
• Hermann A, Rauch BH, Braun M, Schrör K, Weber A-A. Platelet CD40 ligand (CD40L)–subcellular localization, regulation of expression, and inhibition by clopidogrel. Platelets 2001; 12: 74–82
   PubMed Web of Science ®Google Scholar
• Aukrust P, Müller F, Ueland T, Berget T, Aaser E, Brunsvig A, Solum NO, Forfang K, Froland SS, Gullestad L. Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina. Possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes. Circulation 1999; 100: 614–620
   PubMed Web of Science ®Google Scholar
• Viallard JF, Solanilla A, Gauthier B, Contin C, Déchanet J, Grosset C, Moreau JF, Praloran V, Nurden P, Pellegrin JL, et al. Increased soluble and platelet-associated CD40 ligand in essential thrombocythemia and reactive thrombocytosis. Blood 2002; 99: 2612–2614
   PubMedGoogle Scholar
• Wenzel F, Baertl A, Zimmermann N, Hohlfeld T, Giers G, Oldenburg J, Assert R. Different behaviour of soluble CD40L concentrations can be reflected by variations of preanalytical conditions. Clin Hemorheol Microcirc 2008; 39: 417–422
   PubMedGoogle Scholar
• Weber A-A, Hermann A, Rauch BH, Schrör K. Molecular identity of platelet CD40 ligand (CD40L). Thromb Haemost 2001; 86: 718
   Google Scholar
• Henn V, Steinbach S, Büchner K, Presek P, Kroczek RA. The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40. Blood 2001; 98: 1047–1054
   PubMed Web of Science ®Google Scholar
• Nannizzi-Alaimo L, Alves VL, Phillips DR. Inhibitory effects of glycoprotein IIb/IIIa antagonists and aspirin on the release of soluble CD40 ligand during platelet stimulation. Circulation 2003; 107: 1123–1128
   PubMed Web of Science ®Google Scholar
• Furman MI, Krueger LA, Linden MD, Bernard MR, Frelinger AL, Michelson AD. Release of soluble CD40L from platelets is regulated by glycoprotein IIb/IIIa and actin polymerization. J Am Coll Cardiol 2004; 43: 2319–2125
   PubMed Web of Science ®Google Scholar
• Zhao L, Bath PM, May J, Lösche W, Heptinstall S. P-selectin, tissue factor and CD40 ligand expression on platelet-leucocyte conjugates in the presence of a GPIIb/IIIa antagonist. Platelets 2003; 14: 473–480
   PubMed Web of Science ®Google Scholar
• Otterdal K, Pedersen TM, Solum NO. Release of soluble CD40 ligand after platelet activation. Studies on the solubilization phase. Thromb Res 2004; 114: 167–177
   PubMed Web of Science ®Google Scholar
• Jin Y, Nonoyama S, Morio T, Imai K, Ochs HD, Mizutani S. Characterization of soluble CD40 ligand released from activated platelets. J Med Dent Sci 2001; 48: 23–27
   PubMedGoogle Scholar
• Weber A-A, Schrör K. Differential inhibition of adenosine diphosphate- versus thrombin receptor-activating peptide-stimulated platelet fibrinogen binding by abciximab due to different glycoprotein IIb/IIIa activation kinetics. Blood 2001; 98: 1619–1621
   PubMed Web of Science ®Google Scholar
• Stampfuss J-J, Censarek P, Fischer JW, Kaber G, Rauch BH, Freidel K, Fischer U, Schulze-Osthoff K, Grosser T, Grandoch M, et al. Complete down-modulation of P-selectin glycoprotein ligand (PSGL-1) in monocytes undergoing apoptosis. Arterioslcer Thromb Vasc Biol 2008; 28: 1375–1378
   Google Scholar
• Santos-Martínez MJ, Medina C, Jurasz P, Radomski MW. Role of metalloproteinases in platelet function. Thromb Res 2008; 121: 535–542
   PubMed Web of Science ®Google Scholar
• Matthies KMG, Newman JL, Hodzic A. Wngett DG. Differential regulation of soluble and membrane CD40L proteins in T cells. Cell Immunol 2006; 241: 47–58
   PubMed Web of Science ®Google Scholar
• Aktas B, Pozgajova M, Bergmeier W, Sunnarborg S, Offermanns S, Lee D, Wagner DD, Nieswandt B. Aspirin induces platelet receptor shedding via ADAM17 (TACE). J Biol Chem 2005; 280: 39716–39722
   PubMed Web of Science ®Google Scholar
• Menchén, L, Marín Jiménez I, Arias-Salgado EG, Fontela T, Hernández-Sampelayo P, Rodríguez MC, Butta NV. Matrix metalloproteinase 9 is involved in Crohn's disease-associated platelet hyperactivation through the release of soluble CD40 ligand. Gut 2009;58:920-928
   Google Scholar
• Sawicki G, Salas E, Murat J, Miszta-Lane H, Radomski MW. Release of gelatinase A from human platelets mediates aggregation. Nature 1997; 386: 616–619
   PubMed Web of Science ®Google Scholar
• Sawicki G, Sanders ES, Salas E, Wozniak M, Rodrigo J, Radomski MW. Localization and translocation of MMP-2 during aggregation of human platelets. Thromb Haemost 1998; 80: 836–839
   PubMed Web of Science ®Google Scholar